We write this post out of fear that without a significant shift in thinking about HIV prevention, PrEP, which refers primarily to taking the HIV treatment Truvada every day to prevent infection, will be a "slow idea," resulting in thousands of people unnecessarily becoming infected with HIV.
Truvada is just one of the family of HIV drugs produced by Gilead Sciences, which medicates about 75 percent of people treated for HIV, and all of those treatment regimens retail between $1,000 and $2,500 for 30 tablets.
You have to ask yourself if you are truly committed to combatting stigma. If you aren't, if you want to wield stigma as a weapon to impose your point of view, then you are part of the problem. To stigmatize PrEP or the people who take it will only lead to more HIV infections.
The FDA has approved Truvada, an HIV treatment medication, to be taken by uninfected people to protect against HIV. For men who engage in unsafe sex with other men, is this just an excuse to continue to be irresponsible?
I asked a young friend if he had heard of Truvada, the drug recently approved by the FDA for use as pre-exposure prophylaxis, or PrEP, against HIV. It's a pill to prevent HIV transmission. Like most people I know, he hadn't ever heard about PrEP. Sadly, I'm not surprised.
July 16, 2012 could be another major turning point in the fight against HIV/AIDS. Today the FDA approved a supplemental new drug application for the previously approved antiretroviral medication TDF-FTC, to reduce the risk of acquiring HIV by uninfected men and women.